Xenon Pharmaceuticals Inc. (XENE) Tezkor likvidlik ko‘rsatkichi

Xenon Pharmaceuticals Inc (XENE) korporativ emblemasi va logotipi

Daromad yo'qligi sharoitida yuqori R&D xarajatlari Xenon Pharmaceuticals (XENE) kompaniyasida zaxiralarning kamayishi xavfini tug'diradi. Epilepsiya dori vositalarini sinovdan o'tkazishni tezlashtirayotgan sanoat gigantlari bilan hamkorlik ushbu vaziyatni yumshatadi. Tezkor likvidlik koeffitsientlarining tarixi ushbu tendentsiyani tasdiqlaydi, bunda 21.04 eng so'nggi metrika ko'rsatkichini ifodalaydi. Uzoq muddatda, ushbu kasalliklarning surunkli tabiati mahsulotlar tijoratlashtirilgandan so'ng kompaniyaga barqaror daromad generatorini taqdim etadi.

Xenon Pharmaceuticals Inc (XENE) - Shoshilinch likvidlik 04.07.2022dan 30.10.2026gacha

Xenon Pharmaceuticals kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi Xenon Pharmaceuticals Inc|XENE - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor bahosi Xenon Pharmaceuticals Inc|XENE - Biznes qiymati
- balans kapitallashuvi ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Xenon Pharmaceuticals|XENE - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati xenon-pharma.com|XENE - Biznesning umumiy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Xenon Pharmaceuticals|XENE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Xenon|XENE - Kompaniyaning jamlangan qarzi|Qarzning balans qiymatiga nisbati Xenon Pharmaceuticals Inc|XENE - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Xenon Pharmaceuticals|Tezkor likvidlik koeffitsiyenti xenon-pharma.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
XENE - Yakuniy foyda
Kompaniyaning jamlanma tahlili:Xenon Pharmaceuticals Inc, XENE
Xenon ishlab chiqargan mahsulot

Tezkor likvidlik kompaniyaning sekin harakatlanuvchi zaxiralarni hisobga olmagan holda, faqat naqd pul va debitorlik qarzlari yordamida qisqa muddatli qarzlarni zudlik bilan to'lash qobiliyatini belgilaydi. Tezkor likvidlikning tarixiy ko'rsatkichlarini tahlil qilish orqali investor Xenon Pharmaceuticals (XENE) moliyaviy barqarorligini baholaydi, uning to'lov qobiliyati hozirda nevrologiya sohasidagi qimmatli ishlanmalarni moliyalashtirish uchun investitsiya oqimlari va hamkorlarning to'lovlariga kritik darajada bog'liq.

Xenon Pharmaceuticals kimlar bilan raqobatlashadi

Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|Tezkor likvidlik ko‘rsatkichi RGC|Shoshilinch likvidlik koeffitsiyenti AXSM (axsome.com)|Tezkor likvidlik koeffitsiyenti ACAD|VKTX - Shoshilinch likvidlik|Tezkor likvidlik Supernus Pharma SUPN|CPRX: Shoshilinch likvidlik koeffitsiyenti|DNLI - Tezkor likvidlik|Shoshilinch likvidlik harmonybiosciences.com|Biohaven (BHVN) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti AMLX|Tezkor likvidlik ko‘rsatkichi TRVI|PRAX: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Anavex Life Sciences (AVXL)|CBLL: Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti PRTA (Prothena Corporation PLC)|Oraliq qoplash koeffitsiyenti ALEC|Annexon Inc. - Tezkor likvidlik koeffitsiyenti|OMER - Tezkor likvidlik koeffitsiyenti|Neurogene Inc. (NGNE) - Tezkor likvidlik|acimmune.com - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Voyager Therapeutics, Inc.|Tezkor likvidlik ko‘rsatkichi Neumora (NMRA)|Tezkor likvidlik koeffitsiyenti SCLX|Tezkor likvidlik koeffitsiyenti Tevogen Bio Inc. (TVGN)|Tezkor likvidlik koeffitsiyenti ACOG (Alpha Cognition Inc.)|CGTX - Tezkor likvidlik ko‘rsatkichi|Inhibikase Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Cassava Sciences Inc|ASRT (assertiotx.com) - Tezkor likvidlik ko‘rsatkichi|Coya Therapeutics (COYA) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi VTGN|OVID (Ovid Rx) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti ABOS|Oraliq qoplama koeffitsiyenti CervoMed, Inc.|Tezkor likvidlik koeffitsiyenti ATHE (Alterity Therapeutics Limited)|CLNN - Tezkor likvidlik ko‘rsatkichi|PepGen Corp - Tezkor likvidlik koeffitsiyenti|JUNS - Tezkor likvidlik koeffitsiyenti|Relmada Therapeutics, Inc. (RLMD) - Tezkor likvidlik|ANVS (Annovis Bio Inc) - Tezkor likvidlik|Tezkor likvidlik Grace Therapeutics Inc|Firefly Neuro (AIFF) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi KLTO (Klotho Neurosciences Inc)|neurosense-tx.com - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MetaVia Inc. (MTVA) - Shoshilinch likvidlik|NRXS - Tezkor likvidlik|HSDT (Helius Medical) - Shoshilinch likvidlik koeffitsiyenti|PASG: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Neuphoria Therapeutics (NEUP)|Tezkor likvidlik Minerva Neurosciences, Inc.|Shoshilinch likvidlik koeffitsiyenti ATHA (Athira Pharma Inc)|Tezkor likvidlik koeffitsiyenti ADXN|ALZN - Shoshilinch likvidlik|Cyclerion Therapeutics, Inc. - Tezkor likvidlik ko‘rsatkichi|Tezkor likvidlik koeffitsiyenti Protagenic Therapeutics Inc. PTIX|KTTA - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti CRGT (Cortigent, Inc.)|Avenue Therapeutics, Inc (ATXI) - Tezkor likvidlik|Shoshilinch likvidlik BrainStorm Cell Therapeutics Inc. (BCLI)|Tezkor likvidlik ko‘rsatkichi CARA|Shoshilinch likvidlik koeffitsiyenti CHRO (chromocell.com)|Tezkor likvidlik koeffitsiyenti ELYM|ITCI - Shoshilinch likvidlik|Tezkor likvidlik Longboard Pharma LBPH|MRNS: Shoshilinch likvidlik koeffitsiyenti|NKGN - Tezkor likvidlik|Shoshilinch likvidlik neurobopharma.com|Sage Therapeutics (SAGE) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti SNPX|Tezkor likvidlik ko‘rsatkichi TRVN|VIGL: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Anew Medical (WENA)|CERE: Kritik likvidlik koeffitsiyenti